Testing a new drug for Alzheimer's dementia
Treatments studied
Part of Brain & nervous system, Mental health clinical trials.
This study tests whether a new drug called Latrepirdine (DMB-I) is safe and effective for people with mild to moderate Alzheimer's dementia. It may help slow cognitive decline when added to current treatment or used alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 60 and 90 years old.
- You have been diagnosed with mild to moderate Alzheimer's disease.
- You either take memantine 20 mg daily for at least 2 months or have not taken any dementia medications for 2 months or more.
- You have a caregiver who can be with you often and attend all study visits.
- You have not had a stroke or significant brain injury from strokes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental drug for Alzheimer's called NTRX-07. It aims to see if it can slow memory decline for people with mild to moderate Alzheimer's.
This trial tests a new drug, NBI-1117567, for people with mild to moderate Alzheimer's disease who are already taking a standard Alzheimer's medication. The goal is to see if the new drug can help improve symptoms.
This study tests an investigational drug called BEY2153 for people with early Alzheimer's disease. It aims to see if the drug is safe and can help slow memory decline.
This study tests a new drug (BnH-015B) for people with moderate Alzheimer's disease. It also includes a small group of healthy young men for comparison. The goal is to see if the drug is safe and how it works in the body.
This study tests a new drug called NSC001 for people with mild to moderate Alzheimer's. It checks if the drug is safe and if it might help slow memory decline. You'll need a caregiver who can join you at visits and help track your progress.
This trial tests whether a supplement called Neuroaid II can help people with mild to moderate Alzheimer's disease. It is a pill taken alongside your usual Alzheimer's treatments, and the study aims to see if it can slow down memory decline.
Hear when a new Alzheimer Type Dementia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.